DOI: https://doi.org/10.22141/2224-0721.4.68.2015.75018

The State of Sexual Function in Men with Type 2 Diabetes Mellitus

V.Ye. Luchytskyi

Abstract


Sexual dysfunction is considered as one of the most common complications of type 2 diabetes mellitus. Pathological changes in organs of the reproductive system in men suffering from diabetes mellitus are characterized by chronic progressive nature, and these changes adversely affect the course of diabetes. The objective of the study — to examine the state of sexual function in men suffering from type 2 diabetes mellitus. Materials and methods. The study involved 205 men with type 2 diabetes mellitus with complaints about violations of erectile function (average age 48.0 ± 4.6 years). Sexual function disorders were assessed according to the data of questioning patients by international index of erectile function and male sexual formula quantification scale. Results. The average index of erectile function was 17.23 ± 2.08 points vs 26.75 ± 0.79 in the control group (p < 0.01). Index of sexual intercourse satisfaction in patients with type 2 diabetes mellitus was reduced (9.34 ± 0.93) compared with control one (16.18 ± 0.68; p < 0.01). Indicators of orgasmic sensations (6.48 ± 0.72 points) and sexual desire (9.44 ± 0.95 points) in the examined patients were lower than in the control group (9.23 ± 0.26 points (p < 0.05) and 13.93 ± 0.56 (p < 0.01) points, respectively). The highest incidence of erectile dysfunction in men with type 2 diabetes mellitus is in the age group over 40 years. The majority of patients with type 2 diabetes mellitus (62.4 %) had moderate erectile dysfunction. The level of total testosterone in men aged 41–50 years was reduced compared with the control group (3.10 ± 0.47 ng/ml and 5.63 ± 0.90 ng/ml, respectively, p < 0.01), but it was at the lower limit of age norm. In most male patients with type 2 diabetes mellitus, there were disorders of several components of copulative cycle: 3 components — in 55.3 % of patients and 2 components — in 18.4 % of patients.


Keywords


type 2 diabetes mellitus; erectile dysfunction; testosterone

References


National Institutes of Health Consensus Development Panel On Impotence // JAMA. — 1993. — Vol. 270. — P. 83-90.

Corona G., Mannucci E., Petrone L. et al. NCEP — ­ATPIII — Defined Metabolic Syndrome, Type 2 Diabetes Mellitus, and Prevalence of Hypogonadism in Male Patient With Sexual Dysfunction // J. Sex. Med. — 2007. — Vol. 4. — P. 1038-1045.

El-Sacca A. Assotiation of risk factors and medical comorbidities with male sexual dysfunction // J. Sex. Med. — 2007. — Vol. 4. — P. 1691-1700.

Shabsigh R., Arver S., Channer K.S. et al. The triad of erectile dysfunction, hypogonadism and the metabolic syndrome // Int. J. Clin. Pract. — 2008. — Vol. 62. — P. 791-798.

Johannes C.B., Araujo A.B., Feldman H.A. et al. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study // J. Urol. — 2000. — Vol. 163, № 2. — P. 460-463.

Yaman O. et al. The effect of diabetes mellitus treatment and good glycemic control on the erectile function in men with diabetes mellitus-induced erectile dysfunction: A Pilot Study // J. Sex. Med. — 2006. — № 3. — P. 344-348.

Лучицький Є.В. Особливості розвитку еректильної дисфункції у чоловіків з цукровим діабетом 2-го типу // Андрология и сексуальная мед. — 2008. — № 1. — С. 64-68.

Lewis R.W. Epidemiology of sexual dysfunction in Asia compared to the rest of the world // Asian Journal of Andrology. — 2011. — Vol. 13. — P. 152-158.

Fugl-Meyer K.S., Corona G., Hayes R.D. et al. Definitions/Epidemiology/Risk Factors for Sexual Dysfunction // J. Sex. Med. — 2010. — Vol. 7. — P. 1598-1607.

Fedele D., Bortolotti A., Coscelli C. et al. Erectile dysfunction in type 1 and type 2 diabetics in Italy // Int. J. Epidemiol. — 2000. — Vol. 29. — P. 524-531.

Klein R., Klein B.E.K., Lee K.E. et al. Prevalence of self-reported erectile dysfunction in people with long-term IDDM // Diabetes Care. — 1996. — Vol. 19. — P. 135-141.

Malavige L.S., Levy J.C. Erectile dysfunction in diabetes mellitus // J. Sex. Med. — 2009. — Vol. 6. — P. 1232-1247.

Feldman H.A., Goldstein I., Hatzichristou D.G. et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study // J. Urol. — 1994. — Vol. 151. — P. 54-61.

Johannes C.B., Araujo A.B., Feldman H.A. et al. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massacusetts male aging study // J. Urol. — 2000. — Vol. 163. — P. 460-463.

Penson D.F., Latini D.M., Lubek D.P. et al. Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) Database // Diabetes Care. — 2003. — Vol. 26. — P. 1093-1099.

Goldstein I., Lue T.F., Padma-Nathan H. et al. Oral sildenafil in the treatment of erectile dysfunction: Sildenafil study group // N. Engl. J. Med. — 1998. — Vol. 338. — P. 1397-1404.

Eardley I., Fisher W., Rosen R.C. et al. The multinational men's attitudes to life events and sexuality study: the influence of diabetes on self-reported erectile function, attitudes and treatment seeking patterns in men with erectile dysfunction // Int. J. Clin. Pract. — 2007. — Vol. 61. — P. 1446-1453.

Corona G., Mannucci E., Petrone L. et al. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic // Int. J. Impot. Res. — 2006. — Vol. 18. — P. 190-197.

Jacson G. The Metabolic syndrome and erectile dysfunction: multiple vascular risk factors and hypogonadism // Eur. Urol. — 2006. — Vol. 50. — P. 426-427.

Гамидов С.И., Мамедов М.Н., Сотникова Е.М., Гусейнов М.М. Метаболический синдром и эректильная дисфункция // Тер. архив. — 2007. — Т. 10. — С. 21-25.

Geiss L.S., Cowie C.C. Type 2 diabetes and persons at high risk of diabetes. In: Narayan K.M., Williams D., Gregg E.W., Cowie C.C., eds. Diabetes and Public Health: From Data to Policy. — New York, NY: Oxford University Press, 2011. — 15-32.

Hidalgo-Tamola J., Chitaley K. Type 2 diabetes mellitus and erectile dysfunction // J. Sex. Med. — 2009. — Vol. 6. — P. 916-926.

Romeo J.H., Seftel A.D., Madhum Z.T., Aron D.C. Sexual function in men with diabetes type 2: association with glycemic control // J. Urol. — 2000. — Vol. 163. — P. 788-791.

De Angelis L., Marfella R., Siniscalchi M. et al. Erectile and endothelial dysfunction in type II diabetes: a possible link // Diabetologia. — 2001. — Vol. 44. — P. 1155-1160.

Кобяков С.К., Лучицький Є.В., Лучицький В.Є. Статеві порушення у чоловіків, хворих на цукровий діабет, та їх лікування // Сексологія та андрологія. — 2000. — № 5. — С. 44-46.

Seftel A.D., Sun P., Swindle R. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction // J. Urol. — 2004. — Vol. 171. — P. 2341-2345.

Esposito K., Giugliano F., Ciotola M. et al. Obesity and sexual dysfunction, male and female // Int. J. Impot. Res. — 2008. — Vol. 20. — P. 358-365.

Borges R., Temido P., Sousa L. et al. Metabolic syndrome and sexual (dys)function // J. Sex. Med. — 2009. — № 6. — P. 2958-2975.

Musicki B., Burnett A.L. Endothelial dysfunction in diabetic erectile dysfunction // Int. J. Impot. Res. — 2007. — № 19. — P. 1129-1138.

Moreland R.B. Pathophysiology of erectile dysfunction: the contributions of trabecular structure to function and the role of functional antagonism // Int. J. Impot. Res. — 2000. — № 12 (Suppl. 4). — Р. 39-46.

Wespes E., Goes P.M., Schiffmann S. et al. Computerized analysis of smooth muscle fibers in potent and impotent patients // J. Urol. — 1991. — № 146. — Р. 1015-1017.

Bivalacqua T.J., Usta M.F., Champion H.C. et al. Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease // J. Androl. — 2003. — № 24 (Suppl. 6). — Р. 17-37.

Bivalacqua T.J., Musicki B., Usta M.F. et al. Endothelial nitric oxide synthase gene therapy for erectile dysfunction // Curr. Pharm. Des. — 2005. — № 11. — Р. 4059-4067.

Traish A.M., Goldstein I., Kim N.N. Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction // Eur. Urol. — 2007. — № 52. — Р. 54-70.

Singh R., Artaza J.N., Taylor W.E. et al. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway // Endocrinology. — 2003. — Vol. 144. — Р. 5081-5088.

Hwang T.I., Chen H.E., Tsai T.F., Lin Y.C. Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone // Int. J. Impot. Res. — 2006. — № 18. — Р. 400-404.

Akishita M., Hashimoto M., Ohike Y. et al. Low testosterone level is an independent determinant of endothelial dysfunction in men // Hypertens Res. — 2007. — № 30. — Р. 1029-1034.

Solomon H., Man J.W., Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator // Heart. — 2003. — Vol. 89. — Р. 251-253.

Watts G.F., Chew K.K., Stuckey B.G. The erectile-endothelial dysfunction nexus: new opportunities for cardiovascular risk prevention // Nat. Clin. Pract. Cardiovasc. Med. — 2007. — № 4. — Р. 263-273.

Wespes E., Raviv G., Vanegas J.P. et al. Corporeal veno-occlusive dysfunction: a distal arterial pathology? // J. Urol. — 1998. — Vol. 160. — P. 2054-2057.

Bivalacqua T.J., Usta M.F., Champion H.C. et al. Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease // J. Androl. — 2003. — № 24 (Suppl. 6). — Р. 17-37.

Hackett G. Impotence-the most neglected complication of diabetes // Diabetes Res. — 1995. — № 28. — P. 75-83.

Rosen R., Riley A., Wagner G. et al. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction // Urology. — 1997. — № 49. — P. 822-830.

Marumo K., Nagatsuma K., Murai M. Effect of aging and diseases on male sexual function assessed by the International Index of Erectile Function // Nippon Hinyokika Gakkai Zasshi. — 1999. — Vol. 90, № 12. — P. 911-919.

Общая сексопатология / Под ред. Г.С. Васильченко. — 2-е изд., перераб. и доп. — М.: Медицина, 2005. — 512 с.

Кобяков С.К., Лучицкий Е.В., Буглак М.И. Синдромологическая характеристика половых расстройств у мужчин, больных сахарным диабетом // Клиническая и экспериментальная патология. — 2002. — T. 1, № 1. — C. 38-41.

Roth A., Kalter-Leibovici O., Kerbis Y. et al. Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1,412 Israel men // Clin. Cardiol. — 2003. — Vol. 26, № 1. — P. 25-30.

Giuliano F.A., Leriche A, Jaudinot E.O. et al. Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension or both // Urology. — 2004. — Vol. 64. — P. 1196-1201.

Mulhall J., Teloken P., Brock G., Kim E. Obesity, Dyslipidemias and Erectile Dysfunction: A Report of a Subcomittee of the Sexual Medicine Societe of North Americ // J. Sex. Med. — 2006. — № 3. — P. 778-786.

Standard Practice in Sexual Medicine / Ed. by H. Porst, J. Buvat, ISSM Standard Committee. — Blackwell Publishing, 2006. — P. 31-115.

Selvin E., Burnett A.L., Platz E.A. Prevalence and Risk Factors for Erectile Dysfunction in the US // The American Journal of Medicine. — 2007. — Vol. 120. — P. 151-157.

Lewis R.W., Fugl-Meyer K.S., Bosch R. et al. Epidemio-logy/Risk Factors of Sexual Dysfunction // J. Sex. Med. — 2004. — Vol. 1. — P. 35-39.

Borges R., Temido P., Sousa L. et al. Metabolic Syndrome and Sexual (Dys)function // J. Sex. Med. — 2009. — № 6. — P. 2958-2975.

El-Sacca A. Assotiation of Risk Factors and Medical Comorbidities with Male Sexual Dysfunction // J. Sex. Med. — 2007. — № 4. — P. 1691-1700.

Лучицький В.Є. Андрогендефіцитний стан у чоловіків, хворих на цукровий діабет 2 типу // Ендокринологія. — 2012. — Т. 17, № 2. — C. 28-36.

Svatberg J. et al. Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip. // Int. J. Impot. Res. — 2008. — Vol. 20, № 4. — P. 378-387.

Dandona P., Dhindsa S. Update: Hypogonadotropic Hypogonadism in Type 2 Diabetes and Obesity // J. Clin. Endocrin. Metab. — 2011. — Vol. 96. — P. 2643-2651.

Лучицький В.Є. Дослідження стану тестикулярного кровотоку у чоловіків з цукровим діабетом 2 типу та пізнім гіпогонадизмом // Досягнення та перспективи експериментальної і клінічної ендокринології. Мат-ли наук.-практ. конф. — Харків, 2010. — C. 78-79.

Oh J.Y., Barrett-Connor E., Wedick N.M., Wingard D.L. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study // Diabetes Care. — 2002. — Vol. 25. — Р. 55-60.

Haffner S.M., Shaten J., Stern M.P. et al. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial // Am. J. Epidemiol. — 1996. — Vol. 143. — Р. 889-897.

Laaksonen D.E., Niskanen L., Punnonen K. et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men // Diabetes Care. — 2004. — Vol. 27. — Р. 1036-1041.

Tibblin G., Alderberth A., Linstedt G., Bjorntorp P. The pituitary-gonadal axis and health in elderly men: a study of men born in 1913 // Diabetes. — 1996. — Vol. 45. — P. 1605-1609.

Yassian A. The link between erectile dysfunction, metabolic syndrome and testosterone deficiency / A. Yassian, F. Saad // Abstract of 23 Annual EAU Congress. — Milan, 2008. — P. 899.

Traish A.M. Are androgens critical for penile erections in humans? / A.M. Traish, A.T. Guay // J. Sexual Medicine. — 2006. — Vol. 5. — P. 382-407.

Ghanem H. Etiology and Risk Factors of Erectile Dysfunction // Porst H., Buvat J., eds. Standard Practice in Sexual Medicine / H. Ghanem, H. Porst. — Blackwell Publishing, 2006. — P. 49-58.

Jackson G. The metabolic syndrome and erectile dysfunction:multiple vascular risk factors and hypogonadism / G. Jackson // Eur. Urol. — 2006. — Vol. 50. — P. 426-427.

Corona G. Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction / G. Corona, E. Mannucci, C. Schulman [et al.] // Eur. Urol. — 2006. — Vol. 50. — P. 595-604.

Kurbatov D. Testosterone improves erectile function in hypogonadal patients with venous leakage / D. Kurbatov, J. Kuznetsky, A. Traish // J. of Andrology. — 2008. — Vol. 29. — P. 630-637.

Aversa M. Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction // J. Clin. Endocrin. — 2003. — Vol. 58, № 3. — P. 632-638.

Saens de Tejada L. Empaired neurogenic and endeotelium-medialect relaxation of penile smooth muscule from diabetic men / L. Saens de Tejada, L. Goldstein, K. Gradroi [et al.] // J. Med. — 1989. — Vol. 320. — P. 1025-1030.

Buvat J., Gooren L.J.,Guay A.T. et al. Endocrine Aspects of Men Sexual Dysfunction. In Sexual. Medicine Sexual Dysfunctions in Men and Women / Ed. Lue T.F., Basson R., Rosen R. et al. — Chapter 11. — P. 347-382.

Wang C.J., Shen S.J., Wu C.C. et al. Penile blood flow study in diabetic impotence // Urol. Int. — 1993. — Vol. 50. — P. 209.

Saito I., Folsom A.R., Brancati F.L. et al. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study // Ann. Int. Med. — 2000. — Vol. 81. — P. 133.

Metro M.J., Broderick G.A. Diabetes and vascular impotence: does insulin dependence increase the relative severity // Int. J. Impot. Res. — 1999. — Vol. 11. — P. 1999.

Sobrevia L., Mann G.E. Dysfunction of the endothelial-nitric oxide signaling pathway in diabetes and hyperglycemia // Exp. Phisiol. — 1997. — Vol. 82. — P. 423.

Behelmans B., Meuleman E., Doesburg W. et al. Erectile dysfunction in diabetic men: the neurogical factor revisited // J. Urol. — 1994. — Vol. 151. — P. 1994.

Камалов К.Г. Состояние копулятивной и репродуктивной функции у мужчин, страдающих сахарным диабетом: Автореф. дис… канд. мед. наук. — М., 1988. — 24 с.

Акопян А.Э. Нейрососудистые расстройства в генезе нарушений сексуального здоровья у мужчин, страдающих сахарным диабетом, и их коррекция: Автореф. дис… канд. мед. наук. — Харьков, 1990. — 22 с.

Pereira da Silva G. Diabetes and sexual dysfunction // Andrologia. — 1993. — Vol. 1. — P. 5-16.






Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2019

 

   Seo анализ сайта